3rd Quarter - Report

THE MCMANUS GROUP for GENENTECH

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to reforming and increasing transparency within the 340B Drug Pricing Program including in H.R. 3290 - To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program. H.R. 4421 - Preparing for All Hazards and Pathogens Reauthorization Act/S.2333 - Pandemic and All-Hazards Preparedness and Response Act Issues related to Pharmacy Benefit Manager reform included in S. 1339 - Pharmacy Benefit Manager Reform Act, H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023, S.127 PBM Transparency Act of 2023, H.R. 4507 -Transparency in Coverage Act of 2023, S. 1967 - PBM Act, S.2973 - Modernizing and Ensuring PBM Accountability Act, H.R. 5378: Lower Costs, More Transparency Act, H.R.2880 - Protecting Patients Against PBM Abuses Act. S.1375/H.R. 830 HELP Copays Act

Foreign entity interest: 100% ownership by F. Hoffman-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, SUI

LobbyistCovered position, as disclosed
JOHN MCMANUS Staff Director W&M Health Subcommittee; LA, Rep. Bill Thomas
ALANNA TEMME LD, Rep. Jon Porter

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4507 (118th), S. 1967 (118th), H.R. 2880 (118th), H.R. 3561 (118th), H.R. 5378 (118th), H.R. 4421 (118th), S. 127 (118th), S. 1375 (118th), H.R. 830 (118th), H.R. 3290 (118th), S. 1339 (118th), S. 2973 (118th), S. 2333 (118th)

Taxation/Internal Revenue Code TAX

Issues related to research and development tax amortization in H.R. 2673 American Innovation and R&D competitiveness Act of 2023

Foreign entity interest: 100% ownership by F. Hoffman-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, SUI

LobbyistCovered position, as disclosed
JOHN MCMANUS —
ALANNA TEMME —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2673 (118th)

Medicare/Medicaid MMM

Access and reimbursement in Medicare Parts B and D. Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. Issues related to maximum fair price in S. 2764/H.R.5391 - Protecting Patient Access to Cancer and Complex Therapies Act

Foreign entity interest: 100% ownership by F. Hoffman-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, SUI

LobbyistCovered position, as disclosed
JOHN MCMANUS —
ALANNA TEMME —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2764 (118th), H.R. 5391 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.